Cite
HARVARD Citation
Jansson, K. et al. (2018). High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. Scientific reports. 8 (1), pp. 1-13. [Online].